SBEV

Splash Beverage Group Inc

0.3301

-0.0443-11.83%

After Hours: 0.3330 +0.0029 +0.88%17:11 07/27 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.3700/0.3744

TODAY RANGE0.2500-0.3700

VOL1.04M

MARKET CAP2.08M

52 WEEK RANGE0.2500-13.40

AVG VOL (3M)7.09M

% TURNOVER16.45%

TURNOVER--

P/E (TTM)-0.0076

% RANGE32.05%

EPS(TTM)-43.3824

P/E(FORWARD)-0.0266

P/B-0.0426

BVPS-7.7512

DIVIDEND--

P/S3.382

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP2.08M

SHARES OUTSTANDING6.30M

NEXT EARNINGS08/12-08/17

FREE FLOAT6.30M

LOT SIZE1

EX-DATE07/27/2026

News

Press Releases

Financial Reports

Profile

TipRanks·1d ago
Upcoming Stock Splits This Week (July 27 to July 31) – Stay Invested
TipRanks·6d ago
Splash Beverage amends investor settlement payment agreements
TipRanks·07/17 09:05
Splash Beverage Group Announces One-for-Four Reverse Split
TipRanks·07/15 08:02
Splash Beverage restructures capital to maintain NYSE listing
Seeking Alpha·07/14 14:16
Splash Beverage announces reverse stock split, settlement with creditors
Dow Jones·07/14 12:45
Press Release: Splash Beverage Group Announces Significant Balance Sheet Improvement and Board Approval of Reverse Stock Split as Company Continues Strategic Transformation
TipRanks·07/13 21:01
Splash Beverage Group Reaches Debt-Reduction Settlement Agreement
TipRanks·07/10 21:01
Splash Beverage Group Raises Capital Through Equity Issuance
Seeking Alpha·07/09 13:39
Splash Beverage receives NYSE American approval of compliance plan
TipRanks·07/09 13:28
Splash Beverage Gains NYSE Compliance Plan, Retains Listing
Seeking Alpha·07/07 12:49
Splash Beverage Group acquires global rights to CannEpil, secures financing and 20-year license
NASDAQ·07/07 11:02
Splash Beverage Secures Global Rights To CannEpil Epilepsy Therapy
TipRanks·07/07 10:25
Splash Beverage enters licensing agreement with Argent BioPharma for CannEpil
Dow Jones·07/07 10:15
*Splash Beverage Announces Exclusive Global Licensing Agreement With Argent BioPharma for CannEpil
Dow Jones·07/07 10:14
Press Release: SPLASH BEVERAGE GROUP ACQUIRES EXCLUSIVE GLOBAL RIGHTS TO CANNEPIL(R), AN EPILEPSY THERAPY WITH ESTABLISHED EUROPEAN PATIENT ACCESS, FDA ENGAGEMENT AND U.S. DEVELOPMENT POTENTIAL

Same Industry

Name/Symbol

Change%

Price

COKE

PEP

SODA

KOF

FMX

CCEP

Coca Cola Co

+1.33%

82.25

FIZZ

MNST

KDP

AKO-A

AKO-B

YGYI

PRMB

COCO

PRMW

The Alkaline Water

WTER

+30.00%

0.039

BRFH

NBEVQ

ZVIA

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.